Renal Failure in Multiple Myeloma

No abstract is available for this paper.

• Publication year

  1990

• Venue

  JAMA Internal Medicine

• Publication date

  1990-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.1990.00040031693017
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.

  1990cited by this paper
• VAD‐based regimens as primary treatment for multiple myeloma

  1990cited by this paper
• Multiple Myeloma and Severe Renal Failure: A Clinicopathologic Study of Outcome and Prognosis in 34 Patients

  1987cited by this paper
• Ten-year survival in multiple myeloma.

  1985cited by this paper
• Beta2 microglobulin in multiple myeloma

  1985cited by this paper
• Chemotherapy for multiple myeloma

  1984cited by this paper
• Long-term survival of patients with multiple myeloma and acute renal failure at presentation.

  1983cited by this paper
• Myeloma protein kinetics following chemotherapy.

  1982cited by this paper
• Prognostic factors in multiple myeloma

  1975cited by this paper
• ACUTE RENAL FAILURE IN MULTIPLE MYELOMA

  1975cited by this paper
• A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

  1975cited by this paper

• Surveillance of Smoldering Myeloma Patients Who Progress to Active Disease Is Associated with Favorable Outcomes.

  2026cites this paper
• Bibliometric and Bioinformatics Analysis of Renal Impairment in Multiple Myeloma: Trends and Research Hotspots, and Associated Genetic Pathways (2000-2023)

  2025cites this paper
• Advances in Supportive Care for Multiple Myeloma-Related Bone Disease—A Review

  2025cites this paper
• Renal Failure-Related Mortality in Multiple Myeloma: United States Trends From 1999 to 2020.

  2025cites this paper
• A Population Pharmacokinetic Analysis to Evaluate the Impact of Renal Impairment on the Pharmacokinetics of Iberdomide.

  2025cites this paper
• An emergency medicine review: Multiple myeloma and its complications.

  2024cites this paper
• Dr. Raymond Alexanian: Pioneering Contributions to Multiple Myeloma Research, Treatment, and the Concept of Curability.

  2024cites this paper
• Lack of Renal Recovery Predicts Poor Survival in Patients of Multiple Myeloma With Renal Impairment.

  2022cites this paper
• Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option

  2022cites this paper
• Myeloma and Related Conditions

  2021cites this paper
• The Pathophysiology of Kidney Involvement in Multiple Myeloma and Monoclonal-Related Disorders

  2021cites this paper
• Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker

  2021cites this paper
• Myeloma Cast Nephropathy and COVID-19: A Case Report of Multiple Myeloma Presenting as Acute Kidney Injury in the Setting of COVID-19

  2021cites this paper
• Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma

  2020cites this paper
• Metal-Enhanced Fluorescence Immunosensor Based on Plasmonic Arrays of Gold Nanoislands on an Etched Glass Substrate

  2020cites this paper
• Fatal renal diseases among patients with hematological malignancies: A population‐based study

  2020cites this paper
• Association of serum calcium levels with renal impairment and all-cause death in Chinese patients with newly diagnosed multiple myeloma: a cross-sectional, longitudinal study

  2020cites this paper
• Molecular nephrology: types of acute tubular injury

  2019cites this paper
• Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple Myeloma

  2019cites this paper
• 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces peripheral blood abnormalities and plasma cell neoplasms resembling multiple myeloma in mice.

  2019cites this paper
• Activin A: a novel urinary biomarker of renal impairment in multiple myeloma

  2019cites this paper
• Myeloma light chain cast nephropathy, a review

  2019cites this paper
• Clinical features and treatment outcome of elderly multiple myeloma patients with impaired renal function

  2019cites this paper
• Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial.

  2018cites this paper
• Lower glomerular filtration rate predicts increased hepatic and mucosal toxicity in myeloma patients treated with high-dose melphalan

  2018cites this paper
• Management of multiple myeloma bone disease: impact of treatment on renal function

  2018cites this paper
• Late-stage myeloma invades kidney without significant effect on renal function: findings from 53 autopsies in a single institute

  2018cites this paper
• Autologous peripheral blood stem cell transplantation in dialysis‐dependent multiple myeloma patients—DAUTOS Study of the Polish Myeloma Study Group

  2018cites this paper
• High-Cutoff Hemodialysis in Myeloma Cast Nephropathy.

  2017cites this paper
• The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapies.

  2017cites this paper
• Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit

  2017cites this paper
• Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial

  2017cites this paper
• Monoclonal gammopathies of renal significance.

  2017cites this paper
• Renal Disease Associated with Monoclonal Gammopathy

  2017cites this paper
• Monoclonal gammopathies of renal significance.

  2017cites this paper
• 4.11 Progress in the Development of Membranes for Kidney-Replacement Therapy

  2017cites this paper
• Managing renal complications in multiple myeloma

  2016cites this paper
• International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment.

  2016cites this paper
• Lenalidomide is effective and safe for the treatment of patients with relapsed multiple myeloma and very severe renal impairment

  2016cites this paper
• Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients.

  2016cites this paper
• Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma

  2016cites this paper
• Diagnosis of monoclonal gammopathy of renal significance.

  2015cites this paper
• Application of J-Aggregate Monolayers in Silica Encapsulated SERS Nanoprobes for Immunophenotyping of B-cell Malignancies

  2015cites this paper
• Dysproteinemias and Kidney Disease

  2015cites this paper
• Chronic Kidney Disease (CKD) in Cancer Patients

  2015cites this paper
• Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment

  2015cites this paper
• Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma

  2015cites this paper
• Optimizing the treatment of patients with multiple myeloma and renal impairment.

  2015cites this paper
• Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients.

  2015cites this paper
• Acute Kidney Injury in Cancer Patients

  2015cites this paper
• [Dialysis-dependent renal failure in patients with multiple myeloma: Reversibility factors].

  2015cites this paper
• Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment

  2015cites this paper
• Treatment of myeloma patients with renal impairment

  2015cites this paper
• Prognostic factors and their correlation with staging in patients with multiple myeloma: a single centre study in North India

  2015cites this paper
• Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma

  2014cites this paper
• Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents.

  2014cites this paper
• The Use of Novel Drugs Can Effectively Improve Response, Delay Relapse and Enhance Overall Survival in Multiple Myeloma Patients with Renal Impairment

  2014cites this paper
• An unusual association of autosomal polycystic kidney disease and multiple myeloma

  2014cites this paper
• Severe acute kidney injury and multiple myeloma: evaluation of kidney and patient prognostic factors.

  2014cites this paper
• Myeloma-related kidney disease.

  2014cites this paper
• High-Cut-off-Filter

  2013cites this paper
• Bortezomib, dexamethasone plus thalidomide for treatment of newly diagnosed multiple myeloma patients with or without renal impairment.

  2013cites this paper
• Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure

  2013cites this paper
• Renal allografts in plasma cell myeloma hematopoietic cell graft recipients: on the verge of an explosion?

  2013cites this paper
• Rein et myélome multiple: Prévalence, facteurs de risque et pronostic.

  2013cites this paper
• Complications and Special Presentations of Plasma Cell Myeloma

  2013cites this paper
• Managing multiple myeloma patients with renal failure

  2013cites this paper
• The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma

  2013cites this paper
• Current treatments for renal failure due to multiple myeloma

  2013cites this paper
• Amyloid arthropathy associated with multiple myeloma: a systematic analysis of 101 reported cases.

  2013cites this paper
• Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma

  2012cites this paper
• Successful treatment of patients with multiple myeloma and impaired renal function with lenalidomide: results of 4 German centers.

  2012cites this paper
• Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases.

  2012cites this paper
• RENAL STATUS OF MULTIPLE MYELOMA PATIENTS IN IBADAN, NIGERIA

  2012cites this paper
• Achieving an early myeloma response in patients with kidney impairment.

  2012cites this paper
• Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury

  2012cites this paper
• Study of the efficacy of new drugs in a mouse model of multiple myeloma

  2012cites this paper
• Novel approaches for reducing free light chains in patients with myeloma kidney

  2012cites this paper
• Prognostic risk factor evaluation in patients with relapsed or refractory multiple myeloma receiving lenalidomide treatment: analysis of renal function by eGFR and of additional comorbidities by comorbidity appraisal.

  2012cites this paper
• Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma

  2012cites this paper
• Successful treatment of patients with newly diagnosed/untreated multiple myeloma and advanced renal failure using bortezomib in combination with bendamustine and prednisone

  2012cites this paper
• Myeloma kidney: improving clinical outcomes?

  2012cites this paper
• Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairment

  2012cites this paper
• Evolving chemotherapy options for the treatment of myeloma kidney: a 40-year perspective.

  2012cites this paper
• Onco-nephrology: AKI in the cancer patient.

  2012cites this paper
• Novel Therapeutic Agents for the Management of Patients with Multiple Myeloma and Renal Impairment

  2012cites this paper
• Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment.

  2011cites this paper
• Renal failure in multiple myeloma: a medical emergency

  2011cites this paper
• Remisión completa en el mieloma múltiple: Impacto pronóstico de las bandas oligoclonales, cociente de cadenas ligeras libres en suero y células plasmáticas residuales en médula ósea

  2011cites this paper
• Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens

  2011cites this paper
• Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach

  2011cites this paper
• Acute Kidney Injury in Cancer Patients

  2011cites this paper
• Online high-efficiency haemodiafiltration achieves higher serum free light chain removal than high-flux haemodialysis in multiple myeloma patients: preliminary quantitative study.

  2011cites this paper
• Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience.

  2011cites this paper
• Screening and Differential Diagnosis of Renal Light Chain-Associated Diseases

  2011cites this paper
• Supportive therapy in multiple myeloma.

  2011cites this paper
• Inpatient Rehabilitation in Persons With Multiple Myeloma‐Associated Fractures: An Analysis of 8 Consecutive Inpatient Admissions

  2011cites this paper
• Changes in Renal Function after Different Tandem Hematopoietic Stem-cell Transplantation Approaches in Patients with Multiple Myeloma

  2011cites this paper
• Renal Disease in Hematological Malignancies

  2011cites this paper
• Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment

  2011cites this paper